EMA Highlights: Green light for new medicines
by Gary Finnegan – The EMA’s influential Committee for Medicinal Products for Human Use (CHMP) approved six new medicines at its June meeting, including a breakthrough hepatitis C… read more.
by Gary Finnegan – The EMA’s influential Committee for Medicinal Products for Human Use (CHMP) approved six new medicines at its June meeting, including a breakthrough hepatitis C… read more.
World Health Matters: Italy by Gary Finnegan – Alcoholic liver disease is one of the most common reasons for liver transplantation but around half of liver transplant recipients… read more.
by René Adam, Guiseppe Tisone and Wolf Bechstein – with ever better immunosuppression regimens, outcomes in liver transplantation have improved beyond what anyone could have imagined when the… read more.
National guidelines for lipids and blood pressure are likely to be a focus of attention at this year’s meeting of the American Diabetes Association.
by Bruce Sylvester – Emerging uses of FDA approved drugs – Immunosuppresant drugs used to prevent organ rejection after transplantation could become used in fighting persistent HIV infection,… read more.
Poster Presentation: Study of alemtuzumab induction with tacrolimus maintenance monotherapy compared to IL2R blockade with tacrolimus/MMF maintenance in kidney transplantation by Adam McLean, Imperial College Kidney & Transplant… read more.
Quality assessment of human kidneys using ex-vivo normothermic perfusion by Adam Barlow, University Hospitals of Leicester – Ex-vivo normothermic perfusion is a viable method of preserving kidneys for… read more.
by Maria Dalby – Genetic polymorphisms are known to influence the pharmacokinetics of tacrolimus and may thus have a significant impact on the clinical outcome.
Maria Dalby reporting on the Oral Presentation by Mari Kilner, Freeman Hospital, Newcastle upon Tyne- Thromboelastography is a method of testing the efficiency of coagulation which measures not… read more.
Maria Dalby reporting on the Oral Presentation by Marc Clancy, Western Infirmary, Glasgow – Although the mainstay of clinical immunosuppression since the 1980s, calcineurin inhibitors (CNIs) are narrow… read more.
Maria Dalby reporting on the Oral Presentation by Teun van Gelder, Erasmus Medical Centre Rotterdam, the Netherlands – Increasing use of generic drugs, escalating research and development costs… read more.
Maria Dalby reporting on the Oral Presentation by Peter Friend, Oxford Transplant Centre, University of Oxford et al. Peter Friend, Oxford Transplant Centre, University of Oxford / Chris… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.